Advanced Scalp Treatment Offers New Hope for Hair Loss Solutions in the Philippines

Exoscalp leverages exosomes—tiny, naturally occurring vesicles that help cells communicate and support regeneration. By introducing carefully prepared exosomes to the scalp, the treatment is designed to create a favorable environment for healthier hair and scalp vitality. While individual results vary, exosome-based therapies are increasingly recognized within aesthetics for their potential role in regenerative support.

“At Mold Manila, our mission is to empower clients with informed choices,” said Adrielle Costales, Founder of Mold Manila. “Exoscalp reflects our commitment to offering innovative, client-centered options for people navigating hair loss—delivered with transparency, care, and a focus on real-world expectations.”

The clinic’s approach begins with a thorough consultation to understand each client’s concerns, hair history, and lifestyle. Based on this assessment, Mold Manila designs a personalized plan that may include Exoscalp alongside supportive scalp-care protocols. The treatment is non-surgical and aims to complement a broader wellness approach.

Mold Manila emphasizes responsible guidance: Exoscalp is a cosmetic treatment and is not a cure for medical conditions. Clients with underlying scalp or health concerns are encouraged to seek advice from licensed medical professionals. Suitability for Exoscalp is evaluated case by case during consultation, and outcomes may differ based on individual factors.

“Our promise is clarity,” Costales added. “We want clients to understand what exosomes are, what Exoscalp is designed to do, and how it may fit into their personal journey—without hype, and with respect for safety and science as it continues to evolve.”

Mold Manila invites interested individuals to learn more about Exoscalp and schedule a consultation at its Quezon City clinic. The team provides guidance on treatment expectations, aftercare, and maintenance, helping clients make confident, well-informed decisions.